CTN Webinar: Secondary Analyses for Clinical Trials in Development.

Presented by Abigail Matthews, PhD (EMMES Corporation), Daniel Feaster, PhD (Florida Node Alliance), George Bigelow, PhD (Mid-Atlantic Node).

Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, December 6, 2013.

This 90 minute webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, discusses secondary analysis planning in the development of clinical trials, interpretation, and reporting. Additionally, there is consideration of the balance between hypothesis generation and maintaining the overall integrity of the trial when secondary analysis occurs after study completion.

Objectives include:

  • Reviewing the statistical issues with analyzing/interpreting secondary analyses;

  • Explaining the importance of secondary outcome and analysis identification during protocol development;

  • Discussing reporting and interpretation of secondary analyses, including the perspective of the CTN Publications Committee.

This webinar is targeted for all research professionals
responsible for the development of research trials and those interested in expanding their understanding of secondary analyses. (Webinar, Video, PDF, English, 2013)

Keywords: Research design | Training | Clinical Coordinating Center webinar

Document No: 1039

Submitted by CarolAnne Saunders, EMMES, 1/2/2014.

Bigelow, George search mail
Feaster, Daniel search mail
Matthews, Abigail search mail
Bookmark and Share

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 1/2014 --